<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4352509/" ref="ordinalpos=1641&amp;ncbi_uid=7302048&amp;link_uid=PMC4352509" image-link="/pmc/articles/PMC4352509/figure/fig2/" class="imagepopup">Figure 2.  From: Insulin Increases Sestrin 2 Content by Reducing Its Degradation through the PI3K/mTOR <span class="highlight" style="background-color:">Signaling</span> <span class="highlight" style="background-color:">Pathway</span>. </a></div><br /><div class="p4l_captionBody">PI3K/mTOR signaling pathway is required for the upregulation of SESN2 level by insulin treatment. HepG2 cells were pretreated with indicated reagents at the indicated concentrations for 1 h, followed by an 18 h further treatment with 100 nM of insulin. Cells were harvested for western blotting. (a) to (c) are representative images of at least three independent experiments.</div></div>